Table 1.
Baseline patient characteristics (FAS)
| Parameter | FAS (N=64) |
|---|---|
| Median age (range), years | 58 (19-76) |
| Sex, n (%) | |
| Male | 47 (73.4) |
| Female | 17 (26.6) |
| ECOG PS, n (%) | |
| 0 | 14 (21.9) |
| 1 | 50 (78.1) |
| History of gastric cancer surgery, n (%) | |
| No | 44 (68.8) |
| Yes | 20 (31.3) |
| HER2 status, n (%) | |
| HER2++ plus FISH+ | 13 (20.3) |
| HER2+++ | 51 (79.7) |
| Location of primary lesion, n (%) | |
| Gastric | 53 (82.8) |
| Gastroesophageal junction | 11 (17.2) |
| Lauren classification, n (%) | |
| Intestinal | 15 (23.4) |
| Diffuse | 7 (10.9) |
| Mixed | 5 (7.8) |
| Unknown | 37 (57.8) |
| Differentiation, n (%) | |
| G1 | 3 (4.7) |
| G2 | 21 (32.8) |
| G3 | 22 (34.4) |
| Gx | 5 (7.8) |
| Unknown | 13 (20.3) |
| Metastasis, n (%) | |
| Liver | 27 (42.2) |
| Lung | 16 (25.0) |
| Lymph node | 46 (71.9) |
| Ovary | 2 (3.1) |
| Peritoneum | 8 (12.5) |
Abbreviations: ECOG PS, Eastern Cooperative Oncology Group Performance Status; FAS, full analysis set; HER2, human epidermal growth factor 2.